Evidence map›Paper›PMID 20236388›Full record

ArticleJournal of neurochemistry2010

The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.

Wenjin Li, Shasha Wu, Muzamil Ahmad, Jianfei Jiang, Hao Liu, Tetsuya Nagayama, Marie E Rose, Vladimir A Tyurin, Yulia Y Tyurina, Grigory G Borisenko and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Targeting Lipid Peroxidation for Cancer Treatment.Molecules (Basel, Switzerland) · 2020
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Wenjin LiGeriatric Research Educational and Clinical Center, VA Pittsburgh Healthcare System, University of Pittsburgh, Pittsburgh, Pennsylvania 15205, USA.
Shasha Wu
Muzamil Ahmad
Jianfei Jiang
Hao Liu
Tetsuya Nagayama
Marie E Rose
Vladimir A Tyurin
Yulia Y Tyurina
Grigory G Borisenko
Natalia Belikova
Jun Chen
Valerian E Kagan
Steven H Graham
University of Pittsburgh · USVA Pittsburgh Healthcare System · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
UNIVERSITY OF PITTSBURGH BRAIN TRAUMA RESEARCH CENTERP50NS030318 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DIXON, C EDWARD · 1995 to 2007
$8.9M
Role of CyPgs UCHL1 in Ischemic Injury and RecoveryR01NS037459 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GRAHAM, STEVEN H · 1999 to 2018
$5.4M
Pulmonary Phosphatidylserine Oxidation in ApoptosisR01HL070755 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2002 to 2011
$3.0M
REGULATION OF TRANSMITTER RELEASE IN THE DORSAL HORNR01NS037549 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MACDERMOTT, AMY B · 1998 to 2001
$418k
Cytochrome c mechanism of ROS signaling in apoptosisR03TW007320 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2007 to 2009
$116k
FIC NIH HHS R03 TW007320FIC NIH HHS R03TW007320NCATS NIH HHS UL1 TR000005NHLBI NIH HHS HL70755NHLBI NIH HHS R01 HL070755NINDS NIH HHS NS37549NINDS NIH HHS P50 NS030318NINDS NIH HHS R01 NS037459
6 · The paper itself

Abstract

Cyclooxygenase-2 (COX-2) activity has been implicated in the pathogenesis of ischemic injury, but the exact mechanisms responsible for its toxicity remain unclear. Infection of primary neurons with an adenovirus expressing wild type (WT) COX-2 increased the susceptibility of neurons to hypoxia. Infection with an adenoviral vector expressing COX-2 with a mutation at the cyclooxygenase site did not increase susceptibility to hypoxia, whereas over-expression of COX-2 with a mutation in the peroxidase site produced similar susceptibility to hypoxia as WT COX-2. Primary neuronal cultures obtained from transgenic mice bearing a mutation in the COX-2 cylooxygenase site were protected from hypoxia. Mice with a mutation in the cyclooxygenase site had smaller infarctions 24 h after 70 min of middle cerebral artery occlusion than WT control mice. COX-2 activity had no effect on the formation of protein carbonyls. Ascorbate radicals were detected by electron paramagnetic resonance as a product of recombinant COX-2 activity and were blocked by COX-2 inhibitors. Similarly, formation of ascorbate radicals was inhibited in the presence of COX-2 inhibitors and in homogenates obtained from COX-2 null mice. Taken together, these results indicate that the cyclooxygenase activity of COX-2 is necessary to exacerbate neuronal hypoxia/ischemia injury rather than the peroxidase activity of the enzyme.

Indexed as

AnimalsArachidonic AcidAscorbic AcidBrain InfarctionCatalytic DomainCell LineCells, CulturedCyclooxygenase 2Cyclooxygenase 2 InhibitorsFree RadicalsHumansHypoxia-Ischemia, BrainMiceMice, TransgenicNerve DegenerationOxidative StressArachidonic AcidAscorbic AcidCyclooxygenase 2Cyclooxygenase 2 InhibitorsFree RadicalsPeroxidaseProstaglandin H2Ptgs2 protein, mouse

Identifiers

PMID20236388
PMCPMC2860550
OpenAlexW2088993176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.